Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Stroke. 2017 Sep 20;48(10):2848–2854. doi: 10.1161/STROKEAHA.117.017713

Figure 6. NBO reduced blood occludin and improved neurological functions in AIS patients.

Figure 6

A). Blood occludin levels in normoxia and NBO-treated AIS patients. N=8. B). NIHSS scores of AIS patients. N=9. #P<0.05 versus normoxia group at the same time point. Data were presented as means ± SEM.